Mexico - Delayed Quote MXN
RECURSION PHARMACEUTICALS INC (RXRX.MX)
124.00
0.00
(0.00%)
As of March 11 at 11:00:43 AM CST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 9 | 9 |
| Avg. Estimate | 18.08M | 19.78M | 88.31M | 135.11M |
| Low Estimate | 6M | 5M | 28.1M | 36.39M |
| High Estimate | 34.3M | 34.9M | 175M | 245.36M |
| Year Ago Sales | 13.79M | 14.42M | 58.84M | 88.31M |
| Sales Growth (year/est) | 31.10% | 37.22% | 50.09% | 52.99% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RXRX.MX | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/10/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Maintains | Leerink Partners: Market Perform to Market Perform | 2/28/2025 |
| Reiterates | Needham: Buy to Buy | 2/6/2025 |
| Maintains | Keybanc: Overweight to Overweight | 1/8/2025 |
| Reiterates | Needham: Buy to Buy | 12/11/2024 |
Related Tickers
8QQ.SG AbCellera Biologics Inc
2.2400
-0.04%
OBSEF ObsEva SA
0.0001
0.00%
RCKTW Rocket Pharmaceuticals, Inc.
0.0850
+70.00%
SCNI Scinai Immunotherapeutics Ltd.
2.5100
+0.80%
BION.SW BB Biotech AG Ord
28.25
-0.70%
ELVN Enliven Therapeutics, Inc.
17.82
+0.28%
IDIA.SW Idorsia Ltd
1.1460
-1.04%
ENVB Enveric Biosciences, Inc.
1.3600
+5.43%
CYBN.NE Cybin Inc.
9.70
+1.57%
PEPG PepGen Inc.
1.6300
+1.24%